SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Felix B who wrote (2899)4/12/2020 5:02:04 AM
From: CuttingEdge Bio  Respond to of 3557
 
Ah yes, probably something whose phase 2 will prove a mirage in phase 3, much like some old ones like opthotech did.



To: Felix B who wrote (2899)4/12/2020 3:04:23 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 3557
 
Are you possibly thinking of AGN’s abicipar pegol, which is currently under FDA review? If so, it may not be much of a concern: investorshub.advfn.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News